Solid/Semi-Solid Dosage

Apr 05, 2018
By Pharmaceutical Technology Editors
Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.
Mar 02, 2018
Pharmaceutical Technology
Assessing potential formulation and manufacturing issues in early development phases can improve a drug’s chances for success.
Mar 01, 2018
Pharmaceutical Technology
Tableting instruments (i.e., compaction simulators) that simulate high-speed presses can be used in a quality-by-design (QbD) approach to perform in-depth material characterization and direct scale-up.
Feb 22, 2018
This article examines IVBE testing requirements for topical creams and explores some of the analytical techniques necessary.
Jan 11, 2018
By Pharmaceutical Technology Editors
The company completed its oral solid dose production facility in Suzhou, China.
Jan 02, 2018
Pharmaceutical Technology
The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
Nov 02, 2017
Pharmaceutical Technology
Model-based formulation and technology selection methodologies facilitate rapid product development.
Nov 02, 2017
Pharmaceutical Technology
Pharmaceutical companies are increasingly adopting patient-centric formulation development to ensure that drug products adequately meet the needs of end-users in all target patient populations.
Nov 02, 2017
Pharmaceutical Technology
Experts from Colorcon share insights on how manufacturers can play a role in minimizing the risk of medication errors by ensuring that the medicines they develop are well differentiated, especially between dosages of the same product.
Nov 02, 2017
Pharmaceutical Technology
Ralph Gosden, head of product development at Catalent’s Swindon, United Kingdom site, explains the opportunities of orally disintegrating tablets as a patient-centric dosage form.
native1_300x100
lorem ipsum